(NP (NP (NP Molecular/JJ mechanisms/NNS) (PP of/IN (NP steroid/NN action/NN)) :/:) (NP (NP a/DT novel/JJ type/NN) (PP of/IN (NP (NP cross-talk/NN) (PP between/IN (NP-COOD (NP glucocorticoids/NNS) and/CC (NP NF-kappa/NN B/NN transcription/NN factors/NNS))))) ./.))
(S (PP Despite/IN (NP (NP the/DT widespread/JJ use/NN) (PP of/IN (NP glucocorticoids/NNS)) (PP in/IN (NP (NP the/DT treatment/NN) (PP of/IN (NP (NP diseases/NNS) (VP characterized/VBN (NP */-NONE-) (PP by/IN (NP-LGS inflammation/NN))))))))) ,/, (NP-SBJ-29 (NP the/DT molecular/JJ mechanism/NN -LRB-/-LRB- s/NNS -RRB-/-RRB-) (SBAR (WHPP-30 by/IN (WHNP which/WDT)) (S (NP-SBJ these/DT hormones/NNS) (VP exert/VBP (NP this/DT beneficial/JJ effect/NN) (PP in/IN (NP (NP patients/NNS) (PP with/IN (NP asthma/NN)))) (PP *T*-30/-NONE-))))) (VP remains/VBZ (S (NP-SBJ-31 *-29/-NONE-) (VP to/TO (VP be/VB (VP elucidated/VBN (NP *-31/-NONE-)))))) ./.)
(S (ADVP Therefore/RB) ,/, (NP-SBJ we/PRP) (VP have/VBP (VP studied/VBN (NP (NP the/DT transcriptional/JJ regulation/NN) (PP of/IN (NP (NP intercellular/JJ adhesion/NN molecule-1/NN) (PRN -LRB-/-LRB- (NP ICAM-1/NN) -RRB-/-RRB-)))) (SBAR as/IN (S (NP-SBJ-32 adhesion/NN molecules/NNS) (VP are/VBP (ADJP-PRD likely/JJ (S (NP-SBJ-33 *-32/-NONE-) (VP to/TO (VP play/VB (NP a/DT causal/JJ role/NN) (PP in/IN (NP inflammation/NN)) (PP in/IN (S (NP-SBJ *-33/-NONE-) (VP promoting/VBG (NP (ADJP-COOD (ADJP cell-cell/JJ) and/CC (ADJP cell-matrix/JJ)) interactions/NNS))))))))))))) ./.)
(S (NP-SBJ We/PRP) (VP observed/VBD (SBAR that/IN (S (PP in/IN (NP (NP-COOD (NP a/DT (ADJP (ADJP monocytic/JJ) (PRN -LRB-/-LRB- (NP U937/NN) -RRB-/-RRB-)) (NP *RNR*-34/-NONE-)) and/CC (NP a/DT (ADJP (ADJP bronchial/JJ epithelial/NN) (PRN -LRB-/-LRB- (NP H292/NN) -RRB-/-RRB-) (NP *RNR*-34/-NONE-)))) (NP-34 cell-line/JJ))) (NP-SBJ dexamethasone/NN) (ADVP strongly/RB) (VP suppressed/VBD (NP (ADJP-COOD (ADJP basal/JJ) and/CC (ADJP induced/VBN)) ICAM-1/NN expression/NN))))) ./.)
(S (NP-SBJ (NP Subsequent/JJ analysis/NN) (PP of/IN (NP the/DT human/JJ ICAM-1/NN promoter/NN))) (VP has/VBZ (VP revealed/VBN (SBAR that/IN (S (NP-SBJ-COOD both/CC (NP (NP 12-O-tetradecanoylphorbol/NN 13-acetate/NN) (PRN -LRB-/-LRB- (NP TPA/NN) -RRB-/-RRB-)) and/CC (NP (NP tumour/NN necrosis/NN factor-alpha/NN) (PRN -LRB-/-LRB- (NP TNF-alpha/NN) -RRB-/-RRB-))) (VP upregulate/VBP (NP ICAM-1/NN expression/NN) (PP through/IN (NP (NP the/DT presence/NN) (PP of/IN (NP (NP a/DT (NP (NP nuclear/JJ factor/NN) (PRN -LRB-/-LRB- (NP NF-kappa/NN B/NN) -RRB-/-RRB-)) target/NN sequence/NN) (PRN -LRB-/-LRB- (NP TGGAAATTCC/NN) -RRB-/-RRB-)))))))))) ./.)
(S-COOD (S (NP-SBJ No/DT glucocorticoid/NN recognition/NN sequences/NNS) (VP are/VBP (ADJP-PRD present/JJ (PP in/IN (NP this/DT promoter/NN region/NN))))) and/CC (S (NP-SBJ-35 dexamethasone/NN) (VP is/VBZ (ADVP still/RB) (ADJP-PRD able/JJ (S (NP-SBJ *-35/-NONE-) (VP to/TO (VP repress/VB (NP transcription/NN))))) (SBAR-TMP (WHADVP-36 when/WRB) (S (NP-SBJ-37 the/DT multimerized/JJ NF-kappa/NN B/NN sequence/NN) (VP is/VBZ (VP transactivated/VBN (NP *-37/-NONE-) (PP by/IN (NP TNF-alpha/NN)) (PP-TMP upon/IN (NP (NP transfection/NN) (PP in/IN (NP 293/CD cells/NNS)))) (ADVP *T*-36/-NONE-))))))) ./.)
(S (NP-SBJ We/PRP) (VP propose/VBP (SBAR that/IN (S (NP-SBJ (NP direct/JJ interaction/NN) (PP between/IN (NP-COOD (NP the/DT glucocorticoid/NN receptor/NN) and/CC (NP nuclear/JJ factor-kappa/NN B/NN factors/NNS)))) (VP is/VBZ (ADVP at/IN least/JJS) (NP-PRD (NP a/DT partial/JJ explanation/NN) (PP for/IN (NP (NP the/DT effects/NNS) (PP of/IN (NP this/DT hormone/NN)) (PP in/IN (NP inflammatory/JJ diseases/NNS))))))))) ./.)
